Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 140
interventional 106
Observational 29
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Device 35
Procedure 14
Other 12
Drug|placebo 11
Behavioral 10
Drug 8
Biological 2
Device|Other 2
Behavioral|Device|Procedure 1
Behavioral|Drug|Other 1
Behavioral|Drug|placebo 1
Behavioral|Other 1
Biological|placebo 1
Device|Other|Procedure 1
Device|Procedure 1
Diagnostic Test 1
Dietary Supplement|Other 1
Dietary Supplement|placebo 1
Other|Procedure 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 37
NA 8
United Kingdom 8
Denmark 7
France 7
Norway 6
Sweden 4
Egypt 2
Switzerland 2
Turkey 2
Australia 1
Belgium 1
Brazil 1
Bulgaria 1
Canada 1
Canada|Finland|France|Germany|Italy|Norway|Spain 1
Canada|United Kingdom 1
Czech Republic|France|Germany|Hungary|Italy|Poland|Spain|Sweden|United Kingdom 1
Denmark|United Kingdom 1
France|Italy|Netherlands 1
Germany 1
Hong Kong 1
Hungary 1
Israel 1
Korea, Republic of 1
Poland 1
Singapore 1
Spain 1
United States|Austria|Denmark|Germany|Netherlands|Spain|Sweden|United Kingdom 1
United States|Canada 1
United States|Denmark|France 1
United States|Germany|Sweden|United Kingdom 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 78
2 7
3 4
4 3
5 3
6 2
9 3
11 1
13 2
14 1
15 1
51 1

Phase

Phase Study_Count
N/A 68
Phase 1 12
Phase 3 7
Phase 1/Phase 2 6
Phase 4 5
Phase 2 4
Early Phase 1 2
Phase 2/Phase 3 2

Number of Arms

Number_of_Arms Count_of_Studies
1 32
2 46
3 14
4 8
5 2
NA 4

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 12 7.0000 5.0 6.00000 40.00 24 16.0000 5.0
1st Qu. 14 45.0000 15.5 16.75000 43.00 38 59.5000 7.0
Median 16 75.0000 22.5 24.00000 94.00 52 158.0000 30.0
Mean 16 161.4328 31.0 25.66667 161.25 52 157.1429 52.4
3rd Qu. 18 177.0000 28.5 33.50000 212.25 66 253.5000 80.0
Max. 20 1718.0000 126.0 49.00000 417.00 80 300.0000 140.0

Trial Group Type

group_type Group_Count
Experimental 101
Active Comparator 58
Placebo Comparator 18
No Intervention 16
Other 8
Sham Comparator 7
NA 4

Intervention Model

intervention_model Study_Count
Parallel Assignment 48
Single Group Assignment 34
Crossover Assignment 16
Factorial Assignment 5
Sequential Assignment 2
NA 1

Primary Purpose

primary_purpose Study_Count
Treatment 81
Prevention 6
Diagnostic 5
Health Services Research 5
Basic Science 3
Supportive Care 3
Other 2
NA 1

Observational Studies

Studies by Country

Country Study_Count
United States 11
France 7
NA 3
Belgium 1
Brazil 1
Denmark 1
Israel 1
Norway 1
Switzerland 1
Tunisia 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 22
2 2
8 2
14 1
19 1
20 1

Enrollment Metrics

Measure Observational
Min 20.0000
1st Qu 33.0000
Median 120.0000
Mean 261.5517
3rd Qu 298.0000
Max 1641.0000

Observation Model

observational_model Study_Count
Cohort 16
Case-Only 6
Case-Control 3
Case Control 2
Defined Population 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 16
Cross-Sectional 8
Retrospective 3
Longitudinal, Prospective 1
Other 1

Registries

Studies by Country

Country Study_Count
Denmark 1
France 1
France|Germany 1
Italy 1
United States 1

Sites per Study

Site_count Study_Count
1 2
2 2
16 1

Enrollment Metrics

Measure Registries
Min 17.0
1st Qu 68.0
Median 70.0
Mean 96.6
3rd Qu 94.0
Max 234.0

Registry Model

observational_model Study_Count
Cohort 4
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 5

Follow-up

target_duration Study_Count
1 Day 1
1 Year 1
15 Months 1
2 Years 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03394794 Study of the Efficacy of 4 Treatments for Fecal Incontinence in Community-dwelling Women https://ClinicalTrials.gov/show/NCT03394794 Completed Hospital de Mataró 2016-12-01
NCT03825575 Sacral Neuromodulation as Treatment for Fecal Incontinence https://ClinicalTrials.gov/show/NCT03825575 Recruiting McMaster University 2021-02-28
NCT03317938 Studies in Patients With Defecatory Disorders https://ClinicalTrials.gov/show/NCT03317938 Recruiting Giome 2020-12-31
NCT03278613 Neuromodulation for Accidental Bowel Leakage https://ClinicalTrials.gov/show/NCT03278613 Completed NICHD Pelvic Floor Disorders Network 2020-03-09
NCT03261622 Sacral Nerve Stimulation for Faecal Incontinence - Placebo or Clinical Effective https://ClinicalTrials.gov/show/NCT03261622 Recruiting University of Aarhus 2019-11-01
NCT03252951 Physical Therapy for Anal Incontinence https://ClinicalTrials.gov/show/NCT03252951 Recruiting San Diego State University 2022-06-30
NCT02406859 Utility of an Animated Bowel Biofeedback Training Routine to Improve Bowel Function in Individuals With SCI https://ClinicalTrials.gov/show/NCT02406859 Completed VA Office of Research and Development 2017-06-30
NCT03140852 Community-Based Continence Promotion: Sustaining Healthy Aging in Place (SHAIP) Through Mind Over Matter (MOM) https://ClinicalTrials.gov/show/NCT03140852 Completed University of Wisconsin, Madison 2017-11-01
NCT03102645 Does Single Dose Imipramine Affect the Opening Pressure of the Urethral and Anal Sphincter? https://ClinicalTrials.gov/show/NCT03102645 Completed Bispebjerg Hospital 2017-06-21
NCT03080753 Treatment of Anal Incontinence With Intersphincteric Implants https://ClinicalTrials.gov/show/NCT03080753 Active, not recruiting Region Skane 2021-12-31
NCT03078634 The Multi-disciplinary Treatment of Functional Gut Disorders Study https://ClinicalTrials.gov/show/NCT03078634 Active, not recruiting St Vincent’s Hospital Melbourne 2019-02-28
NCT02991833 Developing Of A New Incontinence Care Product https://ClinicalTrials.gov/show/NCT02991833 Completed Ege University 2015-04-30
NCT02989545 The Use of an “Anal-Tape” in Patients With Fecal Incontinence https://ClinicalTrials.gov/show/NCT02989545 Completed Shaare Zedek Medical Center 2018-12-31
NCT02875665 Feasibility Study of the Use of the gekoTM Device for Faecal Incontinence in Older People Living at Home or in Care Homes https://ClinicalTrials.gov/show/NCT02875665 Completed Firstkind Ltd 2017-08-31
NCT02828384 Comparing the Effectiveness of Two Dietary Interventions for Fecal Incontinence https://ClinicalTrials.gov/show/NCT02828384 Completed University of Michigan 2019-06-30
NCT02812823 Comparison of Anorectal Manometry and 3D Manometry in Diagnosis of Functional Disorders in Children https://ClinicalTrials.gov/show/NCT02812823 Recruiting Medical University of Warsaw 2019-03-31
NCT02677753 Percutaneous Nerve Evaluation With Fluoroscopy Versus Without https://ClinicalTrials.gov/show/NCT02677753 Completed University of Louisville 2019-04-30
NCT02671747 Pilot: Mind Over Matter: Healthy Bowels, Healthy Bladder https://ClinicalTrials.gov/show/NCT02671747 Completed University of Wisconsin, Madison 2016-10-01
NCT02643108 Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women https://ClinicalTrials.gov/show/NCT02643108 Recruiting Karolinska Institutet 2020-12-31
NCT02627729 J-Pouch vs Side-to-End Anastomosis After Hand-Assisted Laparoscopic Low Anterior Resection for Rectal Cancer https://ClinicalTrials.gov/show/NCT02627729 Completed Dr.Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi 2012-04-30
NCT02556151 Neuromodulation Therapy for Fecal Incontinence https://ClinicalTrials.gov/show/NCT02556151 Completed Augusta University 2018-03-31
NCT02550899 Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence https://ClinicalTrials.gov/show/NCT02550899 Completed Karolinska Institutet 2014-02-28
NCT02530216 Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes https://ClinicalTrials.gov/show/NCT02530216 Completed Cedars-Sinai Medical Center 2018-02-07
NCT02436057 Development and Validation of the Automated Evaluation of Gastrointestinal Symptoms (AEGIS) Platform https://ClinicalTrials.gov/show/NCT02436057 Completed Cedars-Sinai Medical Center 2015-12-31
NCT02435069 A Within Subjects Comparison of Two Antegrade Flushing Regimens in Children https://ClinicalTrials.gov/show/NCT02435069 Completed Nemours Children’s Clinic 2017-03-28
NCT02428595 A Clinical Evaluation of the Eclipseâ„¢ System, a Vaginal Bowel Control (VBC) Therapy for Fecal Incontinence in Women https://ClinicalTrials.gov/show/NCT02428595 Completed Pelvalon, Inc. 2018-07-18
NCT02384499 Treatment of Fecal Incontinence Using Allogenic-Adipose-derived Mesenchymal Stem Cells: A Prospective, Dose Escalation, Randomized, Placebo-controlled, Parallel-group, Single-blind, Single-center Pilot Study https://ClinicalTrials.gov/show/NCT02384499 Completed Yonsei University 2017-06-30
NCT02383758 An Interdisciplinary Approach to the Treatment of Encopresis in Children With Autism Spectrum Disorders https://ClinicalTrials.gov/show/NCT02383758 Completed Emory University 2017-01-01
NCT02355834 Faecal Incontinence iNtervention Study https://ClinicalTrials.gov/show/NCT02355834 Completed London North West Healthcare NHS Trust 2017-08-31
NCT02349334 UK Trial of Percutaneous Tibial Nerve Stimulation in Patients With Faecal Incontinence https://ClinicalTrials.gov/show/NCT02349334 Completed Queen Mary University of London 2014-02-28
NCT02308631 Endoscopically Assisted Colostomy With Colopexy for Critically Ill Patients Without General Anesthesia or Laparotomy https://ClinicalTrials.gov/show/NCT02308631 Completed University of Sao Paulo 2014-08-31
NCT02299557 The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients https://ClinicalTrials.gov/show/NCT02299557 Completed RDD Pharma Ltd 2015-06-30
NCT02292628 Study, Double Blind, Randomized, Comparing Two Groups to Evaluate the Safety and Efficacy of Autologous Mesenchymal Stem Cells From Adipose Tissue (CMMAd) in the Treatment of the Faecal Incontinence https://ClinicalTrials.gov/show/NCT02292628 Completed Andalusian Network for Design and Translation of Advanced Therapies 2017-09-30
NCT02270008 Reducing Perinatal Anal Incontinence Through Early Pelvic Floor Muscle Training: a Prospective Pilot Study https://ClinicalTrials.gov/show/NCT02270008 Completed Emory University 2015-06-30
NCT02183740 Effect of an Educational Program for Staff in Nursing Homes Concerning Patients Fecal Incontinence https://ClinicalTrials.gov/show/NCT02183740 Completed Norwegian University of Science and Technology 2015-07-31
NCT02165475 Combination Therapy With Biofeedback, Loperamide and Stool Bulking Agents https://ClinicalTrials.gov/show/NCT02165475 Completed University Hospital, Linkoeping 2005-03-31
NCT01275560 Does the Negativation of the Glucose Hydrogen Breath Test Come Along With a Reduction of the Symptoms of Gaz Incontinence ? https://ClinicalTrials.gov/show/NCT01275560 Completed University Hospital, Rouen 2015-06-30
NCT02008565 Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe) https://ClinicalTrials.gov/show/NCT02008565 Completed NICHD Pelvic Floor Disorders Network 2016-05-31
NCT01946334 Does Body Position Influence Pressure Recording by High-resolution Manometry ? https://ClinicalTrials.gov/show/NCT01946334 Completed Assistance Publique Hopitaux De Marseille 2014-03-31
NCT01939821 A Pilot Study to Evaluate Educational Programs to Improve Fecal Incontinence Care in Nursing Homes https://ClinicalTrials.gov/show/NCT01939821 Completed Norwegian University of Science and Technology 2014-01-31
NCT01778660 Standard Versus Mnemonic Counseling for Fecal Incontinence https://ClinicalTrials.gov/show/NCT01778660 Completed University of New Mexico 2014-02-28
NCT01738607 Dietary Fiber for Fecal Incontinence https://ClinicalTrials.gov/show/NCT01738607 Completed University of Minnesota 2007-06-30
NCT01710579 Normal Values in Ano-rectal 3D High Resolution Manometry https://ClinicalTrials.gov/show/NCT01710579 Completed Hospices Civils de Lyon 2014-09-30
NCT01705535 The Effect of Physiotherapy for the Treatment of Fecal Incontinence. https://ClinicalTrials.gov/show/NCT01705535 Active, not recruiting Copenhagen University Hospital, Hvidovre 2019-07-31
NCT01656720 A Multi-centre, Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group, Dose-ranging Study in Patients With Faecal Incontinence; to Evaluate the Efficacy, Safety and Tolerability of Locally Applied NRL001 Over an 8 Week Treatment Period https://ClinicalTrials.gov/show/NCT01656720 Completed Norgine 2013-12-31
NCT01655498 A Clinical Evaluation of a Vaginal Bowel Control System for the Treatment of Fecal Incontinence in Women (LIFE) https://ClinicalTrials.gov/show/NCT01655498 Completed Pelvalon, Inc. 2014-01-31
NCT01625221 Feasibility Study of the Magnetic Anal Sphincter (FENIX System) https://ClinicalTrials.gov/show/NCT01625221 Completed Torax Medical Incorporated 2012-03-31
NCT01600755 Autologous Cell Therapy for Treatment of Fecal Incontinence https://ClinicalTrials.gov/show/NCT01600755 Active, not recruiting Cook MyoSite 2021-08-31
NCT01528995 Treatment of Fecal Incontinence After Obstetric Anal Sphincter Injuries https://ClinicalTrials.gov/show/NCT01528995 Completed University Hospital of North Norway 2015-09-30
NCT01523522 Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence https://ClinicalTrials.gov/show/NCT01523522 Completed University Hospital, Rouen 2015-10-31
NCT01475474 A Study to Evaluate the Safety, Tolerability and Effectiveness of the Renew Insert in Treating Accidental Bowel Leakage https://ClinicalTrials.gov/show/NCT01475474 Completed Renew Medical 2011-11-30
NCT01406925 Safety and Tolerability of a Single Intra-anal Dose of NRL001 in Healthy Volunteers https://ClinicalTrials.gov/show/NCT01406925 Completed Norgine 2007-05-31
NCT01380132 Safety and Efficacy of Anorectal Application of Dx-gel for Treatment of Anal Incontinence https://ClinicalTrials.gov/show/NCT01380132 Completed Uppsala University Hospital 2009-01-31
NCT04380571 Biofeedback Vs Electrical Stimulation in Treatment of Fecal Incontinence https://ClinicalTrials.gov/show/NCT04380571 Completed Cairo University 2018-12-27
NCT04276350 Efficacy of Acupuncture as a Treatment for Faecal Incontinence https://ClinicalTrials.gov/show/NCT04276350 Recruiting Singapore General Hospital 2020-11-30
NCT04273295 Massage With Senna-based Laxatives Versus Senna-based Laxatives in Managing Overflow Retentive Stool Incontinence https://ClinicalTrials.gov/show/NCT04273295 Completed South Valley University 2019-10-01
NCT04273009 Optimising Treatments for Faecal Incontinence https://ClinicalTrials.gov/show/NCT04273009 Completed London North West Healthcare NHS Trust 2018-08-11
NCT04138602 BTL Emsella Chair Versus Sham for the Treatment of Fecal Incontinence https://ClinicalTrials.gov/show/NCT04138602 Recruiting William Beaumont Hospitals 2020-11-30
NCT04109573 Function Following Laser for Anal Intraepithelial Neoplasia (FLAN) https://ClinicalTrials.gov/show/NCT04109573 Recruiting Homerton University Hospital NHS Foundation Trust 2020-12-31
NCT04097288 Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects https://ClinicalTrials.gov/show/NCT04097288 Recruiting University Hospital Bispebjerg and Frederiksberg 2020-12-31
NCT04066894 Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study https://ClinicalTrials.gov/show/NCT04066894 Recruiting M.D. Anderson Cancer Center 2025-07-31
NCT04063293 PRP Injection Into Anal Sphincters for Fecal Incontinence https://ClinicalTrials.gov/show/NCT04063293 Recruiting Istanbul Medipol University Hospital 2020-08-15
NCT04027335 Use of the Leva Pelvic Digital Health System in Women With Fecal Incontinence https://ClinicalTrials.gov/show/NCT04027335 Recruiting Renovia, Inc. 2020-06-01
NCT03940573 Pursuit: Real World Use of the Eclipse System https://ClinicalTrials.gov/show/NCT03940573 Recruiting Pelvalon, Inc. 2021-12-31
NCT03899181 Translumbosacral Neuromodulation for FI https://ClinicalTrials.gov/show/NCT03899181 Recruiting Augusta University 2023-02-28
NCT03882632 Fat Grafting Technique for Fecal Incontinence https://ClinicalTrials.gov/show/NCT03882632 Recruiting Brown Physicians, Inc. 2021-04-30
NCT03811821 Fecal Incontinence Treatment (FIT) Study https://ClinicalTrials.gov/show/NCT03811821 Recruiting University of North Carolina, Chapel Hill 2020-12-31
NCT03746834 NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation https://ClinicalTrials.gov/show/NCT03746834 Completed Uppsala University 2015-12-12
NCT03628833 Incontinence Management System ICU Field Evaluation https://ClinicalTrials.gov/show/NCT03628833 Completed Hill-Rom 2018-12-03
NCT03591393 Pelvic Floor Dysfunction and Its Influence on Body Image and Sexual Function https://ClinicalTrials.gov/show/NCT03591393 Recruiting Universitaire Ziekenhuizen Leuven 2021-06-30
NCT03529487 Intra-anal Oxymetazoline in Healthy Adult Volunteers https://ClinicalTrials.gov/show/NCT03529487 Recruiting RDD Pharma Ltd 2020-04-01
NCT01265485 An Study to Examine the Effect of Coated Suppositories on Anal Pressure in Healthy Subjects https://ClinicalTrials.gov/show/NCT01265485 Completed RDD Pharma Ltd 2011-08-31
NCT01254695 Improving the Efficacy of Sacral Nerve Stimulation for Fecal Incontinence by Alteration of Stimulation Parameters https://ClinicalTrials.gov/show/NCT01254695 Completed University of Aarhus 2011-03-31
NCT01175941 Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence https://ClinicalTrials.gov/show/NCT01175941 Completed Norgine 2011-11-30
NCT01162525 Percutaneous Tibial Nerve Stimulation for Patients With Fecal Incontinence https://ClinicalTrials.gov/show/NCT01162525 Completed Cantonal Hospital of St. Gallen 2017-10-31
NCT01130870 Dose Response Curve - Sacral Nerve Stimulation for Faecal Incontinence https://ClinicalTrials.gov/show/NCT01130870 Completed University of Aarhus 2011-04-30
NCT01099683 Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of a Single Rectal Application of 10 mg NRL001 in Elderly Subjects https://ClinicalTrials.gov/show/NCT01099683 Completed Norgine 2010-07-31
NCT01099670 Safety, Tolerability, Pharmacodynamic and Pharmacokinetics of 7.5, 10, 12.5 or 15 mg NRL001 in a 2 g Suppository for 14 Days https://ClinicalTrials.gov/show/NCT01099670 Completed Norgine 2010-06-30
NCT01095029 Cerebral Responses During Bilateral/Unilateral Sacral Nerve Stimulation for Idiopathic Faecal Incontinence https://ClinicalTrials.gov/show/NCT01095029 Completed University of Aarhus 2012-08-31
NCT01090739 Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence https://ClinicalTrials.gov/show/NCT01090739 Completed ASTORA Women’s Health 2013-11-30
NCT01069016 Comparison of Sacral Nerve Modulation and Pudendal Nerve Stimulation in Treatment of Fecal Incontinence https://ClinicalTrials.gov/show/NCT01069016 Completed Cantonal Hospital of St. Gallen 2014-07-31
NCT00977652 Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence https://ClinicalTrials.gov/show/NCT00977652 Completed University Hospital, Rouen 2011-06-30
NCT00974909 Percutaneous Tibial Nerve Stimulation in the Treatment of Fecal Incontinence https://ClinicalTrials.gov/show/NCT00974909 Completed Maastricht University Medical Center 2011-10-31
NCT00970320 Prevalence and Treatment of Anal Incontinence (AI) in Primiparous Women https://ClinicalTrials.gov/show/NCT00970320 Completed Ostfold Hospital Trust 2014-04-30
NCT00895388 Effects of Structured Rehabilitation Program on Quality of Life in Rectal Cancer Patients- a Randomized Controlled Trial https://ClinicalTrials.gov/show/NCT00895388 Completed University Hospital of North Norway 2019-11-30
NCT00893607 Effect of Single Doses of 10 mg NRL001 Applied as a Suppository to the Anal Canal or Rectum https://ClinicalTrials.gov/show/NCT00893607 Completed Norgine 2007-08-31
NCT00884832 A Placebo-Controlled Study of Clonidine for Fecal Incontinence. https://ClinicalTrials.gov/show/NCT00884832 Completed Mayo Clinic 2012-08-31
NCT00880880 Improving Women’s Health by Using an Electronic Pelvic Floor Questionnaire https://ClinicalTrials.gov/show/NCT00880880 Completed University of Wisconsin, Madison 2008-08-31
NCT00857467 Study to Investigate Safety and Response to 1 or 2 g Rectal Suppositories Containing 5 or 10 mg NRL001. https://ClinicalTrials.gov/show/NCT00857467 Completed Norgine 2009-12-31
NCT01110681 Study to Evaluate Solesta for Treatment of Fecal Incontinence https://ClinicalTrials.gov/show/NCT01110681 Completed Q-Med AB 2009-11-30
NCT02628626 A Study of Colesevelam in Fecal Incontinence https://ClinicalTrials.gov/show/NCT02628626 Recruiting Mayo Clinic 2020-10-31
NCT03510052 Diet and Fecal Incontinence in Senior Women https://ClinicalTrials.gov/show/NCT03510052 Active, not recruiting University of Pennsylvania 2020-03-15
NCT00767403 Internet Intervention for Childhood Encopresis https://ClinicalTrials.gov/show/NCT00767403 Completed University of Virginia 2012-03-31
NCT00727649 Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence https://ClinicalTrials.gov/show/NCT00727649 Completed VA Office of Research and Development 2013-10-31
NCT00632567 EPIC :Anal Incontinence After Delivery. Secondary Prevention With Caesarean Section. https://ClinicalTrials.gov/show/NCT00632567 Completed Assistance Publique - Hôpitaux de Paris 2016-03-31
NCT00605826 A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence https://ClinicalTrials.gov/show/NCT00605826 Completed Bausch Health Americas, Inc. 2009-11-23
NCT00593996 Evaluation of Potential Vitamin D Effects on Muscle: a Pilot Study https://ClinicalTrials.gov/show/NCT00593996 Completed University of Wisconsin, Madison 2010-05-31
NCT00565136 Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms https://ClinicalTrials.gov/show/NCT00565136 Completed ASTORA Women’s Health 2010-12-31
NCT00551551 Prenatal Pelvic Floor Prevention (3PN) https://ClinicalTrials.gov/show/NCT00551551 Completed Centre Hospitalier Universitaire de la Réunion 2011-09-30
NCT00525291 Triple Target Treatment (3T) Which Combines Stimulation With Amplitude Modulated Middle Frequency (AM-MF), Electromyography (EMG)-Triggered Stimulation and EMG-Biofeedback Compared With EMG-Biofeedback in Anal Incontinence https://ClinicalTrials.gov/show/NCT00525291 Completed University of Giessen 2008-12-31
NCT00345397 A Colonic Tube to Improve Bowel Function in Spinal Cord Injury https://ClinicalTrials.gov/show/NCT00345397 Completed VA Office of Research and Development 2014-03-31
NCT00303030 A Randomized, Controlled, Clinical Trial of Biofeedback and Anal Injections as First Treatment of Fecal Incontinence https://ClinicalTrials.gov/show/NCT00303030 Completed University Hospital of North Norway 2011-06-30
NCT00286520 Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury https://ClinicalTrials.gov/show/NCT00286520 Completed University of Aarhus NA
NCT00200057 Sacral Nerve Stimulation Therapy for the Treatment of Chronic Fecal Incontinence https://ClinicalTrials.gov/show/NCT00200057 Completed MedtronicNeuro 2007-08-31
NCT00200005 Sacral Nerve Stimulation for Anal Incontinence and Bowel Control https://ClinicalTrials.gov/show/NCT00200005 Completed MedtronicNeuro 2006-12-31
NCT00124904 Biofeedback for Fecal Incontinence https://ClinicalTrials.gov/show/NCT00124904 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03386292 Urinary and Anal Incontinence in Tunisian Women https://ClinicalTrials.gov/show/NCT03386292 Completed University of Monastir 2017-09-30
NCT03543566 Bladder Antimuscarinic Medication and Accidental Bowel Leakage https://ClinicalTrials.gov/show/NCT03543566 Completed University of Alabama at Birmingham 2019-01-18
NCT03283540 Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence https://ClinicalTrials.gov/show/NCT03283540 Recruiting Case Comprehensive Cancer Center 2020-07-31
NCT02996357 Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence https://ClinicalTrials.gov/show/NCT02996357 Completed University Ghent 2017-05-31
NCT02792244 First Time Mothers and Anal Incontinence Six Years Postpartum https://ClinicalTrials.gov/show/NCT02792244 Completed Ostfold Hospital Trust 2017-07-31
NCT02772874 Fecal Incontinence Subtypes in Women With Pelvic Floor Disorders https://ClinicalTrials.gov/show/NCT02772874 Completed University of Pennsylvania 2016-06-30
NCT02485522 Diet and Stool Metabolites in Fecal Incontinence https://ClinicalTrials.gov/show/NCT02485522 Completed University of Pennsylvania 2017-02-28
NCT02263170 Assessment of Anatomic, Physiologic and Biomechanical Characteristics of the Anal Canal and Pelvic Floor. An Observational Pilot Study https://ClinicalTrials.gov/show/NCT02263170 Completed University Hospital Inselspital, Berne 2015-11-30
NCT01310426 Risk Factors for Anal Sphincter Damage During Vaginal Delivery https://ClinicalTrials.gov/show/NCT01310426 Completed Hadassah Medical Organization 2014-03-31
NCT01300884 Sierra High Definition Ano-Rectal Manometry https://ClinicalTrials.gov/show/NCT01300884 Completed Augusta University 2011-12-31
NCT01786317 Anal Motor Function in Fecal Incontinence https://ClinicalTrials.gov/show/NCT01786317 Completed University Hospital, Rouen 2015-06-30
NCT01786304 Effect of Sacral Nerve Stimulation on Enteric Nervous System https://ClinicalTrials.gov/show/NCT01786304 Completed University Hospital, Rouen 2016-11-30
NCT01766193 Delivery Method and Risk for Urogenital Prolapse 15-20 Years Later https://ClinicalTrials.gov/show/NCT01766193 Completed Norwegian University of Science and Technology 2014-02-28
NCT01647906 Long Term Safety and Efficacy of Solesta® Injectable Bulking Agent for the Treatment of Fecal Incontinence (SoFI) https://ClinicalTrials.gov/show/NCT01647906 Completed Bausch Health Americas, Inc. 2018-09-15
NCT01632839 Psychometric Validation of a French Version of the PISQ-R and a New Questionnaire About Sexuality https://ClinicalTrials.gov/show/NCT01632839 Completed Centre Hospitalier Universitaire de Nīmes 2017-04-21
NCT01548989 Validation of a New Sexuality Questionnaire for Patients With Urinary Incontinence or Pelvic Organ Prolapse https://ClinicalTrials.gov/show/NCT01548989 Completed Centre Hospitalier Universitaire de Nīmes 2012-07-31
NCT01548976 Validation of a French Version of the PISQ-R https://ClinicalTrials.gov/show/NCT01548976 Completed Centre Hospitalier Universitaire de Nīmes 2012-05-31
NCT04410822 Fecal Incontinence Type Assessment Scale https://ClinicalTrials.gov/show/NCT04410822 Recruiting Pierre and Marie Curie University 2020-06-30
NCT04009356 Impact of Bariatric Surgery in Patients With Morbid Obesity https://ClinicalTrials.gov/show/NCT04009356 Recruiting Central Hospital, Nancy, France 2021-08-01
NCT03976414 Mind Over Matter: Electronic Bladder and Bowel Continence Self-management Program https://ClinicalTrials.gov/show/NCT03976414 Active, not recruiting University of Wisconsin, Madison 2020-03-01
NCT03656601 Tridimensional Pelvic Floor Ultrasound and Quality of Life Scores Questionnaires in Nulliparous or Parous Women https://ClinicalTrials.gov/show/NCT03656601 Active, not recruiting Federal University of São Paulo 2019-10-31
NCT01166399 Behavioral Therapy Of Obstetric Sphincter Tears https://ClinicalTrials.gov/show/NCT01166399 Completed NICHD Pelvic Floor Disorders Network 2011-06-30
NCT03969069 Assessment of Faecal Incontinence With MAPLe https://ClinicalTrials.gov/show/NCT03969069 Recruiting University College London Hospitals 2020-08-31
NCT03536221 What is the Prevalence of Female Pelvic Floor Disorders in Minnesota? https://ClinicalTrials.gov/show/NCT03536221 Completed University of Minnesota 2019-09-30
NCT02836717 Long Term Efficacy of Sacral Nerve Modulation (SNM) in Patients With Constipation or Stool Incontinence https://ClinicalTrials.gov/show/NCT02836717 Completed Cantonal Hospital of St. Gallen 2016-09-30
NCT00729144 Adaptive Behaviors Among Women With Bowel Incontinence: The ABBI Trial https://ClinicalTrials.gov/show/NCT00729144 Completed Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2010-07-31
NCT00677508 Development of an Instrument to Measure Quality of Life in Children With Chronic Constipation and Soiling https://ClinicalTrials.gov/show/NCT00677508 Completed Medical College of Wisconsin 2011-08-31
NCT00230360 Diagnosis of Functional Defecation Disorders in Childhood https://ClinicalTrials.gov/show/NCT00230360 Completed University of Aarhus NA
NCT00213317 Effect of Lumbo-sacral Magnetic Stimulation on Colonic Motility https://ClinicalTrials.gov/show/NCT00213317 Completed University Hospital, Rouen 2008-06-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT01957969 French Post-Inscription Study on Sacral Neuromodulation in the Treatment of Fecal Incontinence https://ClinicalTrials.gov/show/NCT01957969 Completed MedtronicNeuro 2017-12-31
NCT04007250 FENIXâ„¢ Continence Restoration System Registry https://ClinicalTrials.gov/show/NCT04007250 Completed Torax Medical Incorporated 2019-02-27
NCT03933683 Indirect Non-invasive Evaluation of Pudendal Neuropathy https://ClinicalTrials.gov/show/NCT03933683 Active, not recruiting University of Campania “Luigi Vanvitelli” 2019-03-01
NCT03028636 LIBERATE - PRO: Eclipseâ„¢ System Registry https://ClinicalTrials.gov/show/NCT03028636 Completed Pelvalon, Inc. 2019-02-27
NCT03257332 Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Surgery for Rectal Cancer. https://ClinicalTrials.gov/show/NCT03257332 Enrolling by invitation Slagelse Hospital 2020-12-31